ATE548048T1 - Oncomodulin zur behandlung von neurologishen erkrankungen - Google Patents

Oncomodulin zur behandlung von neurologishen erkrankungen

Info

Publication number
ATE548048T1
ATE548048T1 AT01946052T AT01946052T ATE548048T1 AT E548048 T1 ATE548048 T1 AT E548048T1 AT 01946052 T AT01946052 T AT 01946052T AT 01946052 T AT01946052 T AT 01946052T AT E548048 T1 ATE548048 T1 AT E548048T1
Authority
AT
Austria
Prior art keywords
oncomodulin
treatment
neurological diseases
subject
regeneration
Prior art date
Application number
AT01946052T
Other languages
English (en)
Inventor
Larry Benowitz
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of ATE548048T1 publication Critical patent/ATE548048T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1738—Calcium binding proteins, e.g. calmodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT01946052T 2000-06-01 2001-06-01 Oncomodulin zur behandlung von neurologishen erkrankungen ATE548048T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20877800P 2000-06-01 2000-06-01
PCT/US2001/017895 WO2001091783A2 (en) 2000-06-01 2001-06-01 Methods and compositions for producing a neurosalutary effect in a subject

Publications (1)

Publication Number Publication Date
ATE548048T1 true ATE548048T1 (de) 2012-03-15

Family

ID=22776024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01946052T ATE548048T1 (de) 2000-06-01 2001-06-01 Oncomodulin zur behandlung von neurologishen erkrankungen

Country Status (7)

Country Link
US (2) US20020119923A1 (de)
EP (1) EP1289540B1 (de)
JP (1) JP2003534385A (de)
AT (1) ATE548048T1 (de)
AU (2) AU2001268147B2 (de)
CA (1) CA2411666A1 (de)
WO (1) WO2001091783A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020257A2 (de) * 2001-08-29 2003-03-13 Eucro European Contract Research Gmbh & Co. Kg VERWENDUNG VON β-ADRENOZEPTOR-AGONISTEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
EP1542702A4 (de) * 2002-09-27 2008-08-27 Childrens Medical Center Verfahren und zusammensetzungen zur behandlung von neurologischen störungen
WO2004060146A2 (en) * 2002-12-30 2004-07-22 Purdue Research Foundation Method of treatment for central nervous system injury
FR2851247B1 (fr) * 2003-02-19 2007-06-29 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de pathologies degeneratives oculaires
AU2006280946B2 (en) * 2005-08-19 2013-05-02 Neuronetrix Solutions, Llc Controller for neuromuscular testing
AU2007249738A1 (en) * 2006-05-12 2007-11-22 Children's Medical Center Corporation Methods and compositions for treating and preventing peripheral nerve damage
WO2008070769A1 (en) * 2006-12-06 2008-06-12 Medtronic, Inc. Intrathecal catheter
AU2009255973B2 (en) 2008-06-06 2013-08-15 Children's Medical Center Corporation Promoting axon regeneration in the adult CNS through control of protein translation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525416A1 (de) * 1995-07-12 1997-01-16 Bioph Biotech Entw Pharm Gmbh Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems
FR2720069A1 (fr) * 1994-05-19 1995-11-24 Inst Nat Sante Rech Med Dérivés de facteurs de croissance et d'hormones de la superfamille des TGFB, procédé pour leur obtention et leurs applications biologiques.
JP4847634B2 (ja) * 1996-03-22 2011-12-28 ストライカー・コーポレーション 中枢神経系の虚血または外傷の機能的回復を増大させる方法
CA2342208A1 (en) * 1998-09-03 2000-03-16 Kerstin Kriegelstein Use of tgf-beta inhibitors for treating cerebral disorders

Also Published As

Publication number Publication date
US20050059594A1 (en) 2005-03-17
AU6814701A (en) 2001-12-11
AU2001268147B2 (en) 2006-05-04
WO2001091783A3 (en) 2002-07-11
WO2001091783A2 (en) 2001-12-06
EP1289540B1 (de) 2012-03-07
EP1289540A2 (de) 2003-03-12
JP2003534385A (ja) 2003-11-18
CA2411666A1 (en) 2001-12-06
US20020119923A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE202940T1 (de) Mittel und methoden zur behandlung von plaque- krankheiten
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
YU46097A (sh) Nova klasa estara i njihove farmaceutske smeše
WO2004006858A3 (en) Compounds, compositions, and methods employing same
ATE292971T1 (de) (s,s)-reboxetin zur behandlung von peripheren neuropathien
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60036169D1 (de) Methoden zur Behandlung der Hautpigmentierung
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
BG105275A (en) Tan-1057 derivatives
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
TR200200278T2 (tr) Kalsilitik bileşimler
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis